Omnicell Reports Results for First Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Omnicell (OMCL) Tops Q1 EPS by 20c, Revenues Beat; Offers 2Q & FY19 EPS Guidance Above Consensus, Affirms 2Q & FY19 Revenue Outlooks
April 25, 2019 4:38 PM EDTOmnicell (NASDAQ: OMCL) reported Q1 EPS of $0.61, $0.20 better than the analyst estimate of $0.41. Revenue for the quarter came in at $202.5 million versus the consensus estimate of $199.72 million.
"We believe that customers and the market are embracing our Autonomous Pharmacy vision and the impact that... More
